Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.
[inclusion body myositis]
We
investigated
the
molecular
mechanisms
involved
in
the
pathogenesis
of
three
inflammatory
myopathies
,
dermatomyositis
(
DM
)
,
polymyositis
(
PM
)
and
inclusion
body
myositis
(
IBM
)
.
We
performed
microarray
experiments
(
â€
)
using
microdissected
pathological
muscle
fibres
from
15
patients
with
these
disorders
and
five
controls
.
Differentially
expressed
candidate
genes
were
validated
by
immunohistochemistry
on
muscle
biopsies
,
and
the
altered
pathways
were
analysed
in
human
myotube
cultures
.
Up-regulation
of
genes
involved
in
viral
and
nucleic
acid
recognition
were
found
in
the
three
myopathies
but
not
in
controls
.
In
DM
,
retinoic
acid-inducible
gene
1
(
RIG-
I
,
DDX
58
)
and
the
novel
antiviral
factor
DDX
60
,
which
promotes
RIG-
I
-mediated
signalling
,
were
significantly
up-regulated
,
followed
by
IFIH
1
(
MDA
5
)
and
TLR
3
.
Immunohistochemistry
confirmed
over-expression
of
RIG-
I
in
pathological
muscle
fibres
in
5
/
5
DM
,
0
/
5
PM
and
0
/
5
IBM
patients
,
and
in
0
/
5
controls
.
Stimulation
of
human
myotubes
with
a
ligand
of
RIG-
I
produced
a
significant
secretion
of
interferon-β
(
IFN
β
;
p
<
0
.
05
)
and
up-regulation
of
class
I
MHC
,
RIG-
I
and
TLR
3
(
p
<
0
.
05
)
by
IFN
β-dependent
and
TLR
3
-
independent
mechanisms
.
RIG-
I
-mediated
innate
immunity
,
triggered
by
a
viral
or
damage
signal
,
plays
a
significant
role
in
the
pathogenesis
of
DM
,
but
not
in
that
of
PM
or
IBM
.
Diseases
Validation
Diseases presenting
"muscle biopsies"
symptom
cadasil
inclusion body myositis
pyruvate dehydrogenase deficiency
zellweger syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom